Skip to content

Clinical trials

Phase 1 Hemoglobinopathies trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemoglobinopathies Phase: Phase 1 Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20151
20172
20191
20221
20231
20242
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting4
Completed3
Terminated2
Active, not recruiting1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Baylor College of Medicine1
Bellicum Pharmaceuticals1
City of Hope Medical Center1
Duke University1
Guangzhou Women and Children's Medical Center1
Hillhurst Biopharmaceuticals, Inc.1
National Heart, Lung, and Blood Institute (NHLBI)1
ScinnoHub Pharmaceutical Co., Ltd.1
Shenzhen Hemogen1
The 923rd Hospital of Joint Logistics Support Force of People's Liberation Army1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hemoglobinopathies11
Anemia, Sickle Cell6
Thalassemia6
Genetic Diseases, Inborn3
Hematologic Diseases3
Anemia2
Anemia, Diamond-Blackfan2
Anemia, Hemolytic2
Anemia, Hemolytic, Congenital2
Severe Combined Immunodeficiency2

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.